EVP, Chief Insurance Officer Quane Alessandrea C. sold 17,532 shares of Oscar Health Inc. [OSCR]

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Oscar Health Inc. shares valued at $97,019 were sold by Quane Alessandrea C. on Sep 06. At $5.53 per share, Quane Alessandrea C. sold 17,532 shares. The insider’s holdings dropped to 148,804 shares worth approximately $0.75 million following the completion of this transaction.


Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now.

Sponsored


Also, Blackley Richard Scott sold 31,615 shares, netting a total of over 174,951 in proceeds. Following the sale of shares at $5.53 each, the insider now holds 300,000 shares.

Before that, Bopitiya Ranmali had sold 6,167 shares from its account. In a trade valued at $36,077, the EVP & Chief Legal Officer traded Oscar Health Inc. shares for $5.85 each. Upon closing the transaction, the insider’s holdings decreased to 6,167 shares, worth approximately $0.15 million.

As published in a research note from BofA Securities on June 15, 2022, Oscar Health Inc. [OSCR] has been rated down from a Neutral to an Underperform and the price target has been revised to $4.50 from $6. This represents a -12.44% premium over Thursday’s closing price. Analysts at BofA Securities downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in late May. As of February 14, 2022, Goldman has decreased its “Neutral” rating to a “Sell” for OSCR. Earlier on January 06, 2022, Wells Fargo downgraded its rating. Their new recommendation was “an Equal weight” for OSCR stock which previously was a “an Overweight”.

Analyzing OSCR’s Price Performance

On Thursday, Oscar Health Inc. [NYSE: OSCR] plunged -5.77% to $5.06. The stock’s lowest price that day was $5.03, but it reached a high of $5.35 in the same session. During the last five days, there has been a drop of approximately -15.53%. Over the course of the year, Oscar Health Inc. shares have dropped approximately -35.54%. Shares of the company reached a 52-week high of $10.52 on 03/30/22 and a 52-week low of $3.89 on 06/15/22. A 50-day SMA is recorded $6.10, while a 200-day SMA reached $6.78. Nevertheless, trading volume fell to 1.71 million shares from 1.46 million shares the previous day.

Support And Resistance Levels for Oscar Health Inc. (OSCR)

According to the 24-hour chart, there is a support level at 4.94, which, if violated, would cause prices to drop to 4.83. In the upper region, resistance lies at 5.26. The next price resistance is at 5.47. RSI (Relative Strength Index) is 32.01 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.46, which suggests the price will decrease in the coming days. Percent R is at 97.82%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.

Is Oscar Health Inc. subject to short interest?

Stocks of Oscar Health Inc. saw a sharp rise in short interest on Jul 14, 2022 jumping by 1.77 million shares to 10.32 million. Data from Yahoo Finance shows that the short interest on Jun 14, 2022 was 8.55 million shares. A jump of 17.15% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.42 of the overall float, the days-to-cover ratio (short ratio) jumped to 4.42.

Which companies own the most shares of Oscar Health Inc. (OSCR)?

According to Baillie Gifford & Co. filings, the company currently owns 20,785,630 shares, which is about 11.74% of the total OSCR shares outstanding. The investor’s shares have plunged by -596,274 from its previous 13-F filing of 21381904.0 shares. The Vanguard Group, Inc. acquire a 9.36% interest valued at $64.86 million while BlackRock Fund Advisors purchased a 5,424,309 stake. A total of 0 shares of Oscar Health Inc. were bought by Capital Research & Management Co during the quarter, and 38,600 were bought by Millennium Management LLC. In its current portfolio, SSgA Funds Management, Inc. holds 2,069,734 shares valued at $13.72 million.

In terms of Oscar Health Inc. share price expectations, FactSet research, analysts set an average price target of $7.64 in the next 12 months, up nearly 48.98% from the previous closing price of $5.37. Analysts anticipate Oscar Health Inc. stock to reach $9.00 by 2022, with the lowest price target being $6.00. In spite of this, 7 analysts ranked Oscar Health Inc. stock as a Hold at the end of 2022. On December 14, 2021, Goldman assigned a price target of “a Sell” to the stock and initiated coverage with a $6.50.

LEAVE A REPLY

Please enter your comment!
Please enter your name here